Eli Lilly hasactually released a special site to link U.S. clients lookingfor weightproblems treatment to medicalprofessionals, dietprofessionals and its brand-new weight-loss drug, Zepbound
ByTOM MURPHY AP health author
FILE – A indication for Eli Lilly & Co. stands outside their business headoffice in Indianapolis on April 26,2017 Eli Lilly hasactually released a distinct site to link U.S. clients lookingfor weightproblems treatment to medicalprofessionals, dietprofessionals and its brand-new weight-loss drug, Zepbound. The drugmaker stated Thursday, Jan 4, 2024, it will usage the website, called LillyDirect, to set visitors with third-party mail-order drugstores for prescriptions and to care companies through a virtual medical weight-loss center. (AP Photo/Darron Cummings, File) (AP Photo/Darron Cummings, File)
The Associated Press
Eli Lilly hasactually introduced a distinct site to link U.S. clients lookingfor weightproblems treatment to physicians, dietprofessionals and its brand-new weight-loss drug, Zepbound.
The drugmaker stated Thursday it will usage the website, called LillyDirect, to set visitors with third-party mail-order drugstores for prescriptions and to care companies through a virtual medical weight-loss center.
The website likewise uses a directorysite for in-person care and aid with insulins and migraine treatments.
Lilly states the medicalprofessionals linked through the site are independent and not paid to promote its items, and the drugmaker likewise isn’t paid to sendout recommendations to them.
In November, U.S. regulators authorized Zepbound, a variation of the popular diabetes treatment Mounjaro, to be utilized as a weight-loss treatment. The drug signsupwith Novo Nordisk’s Wegovy in a hot